Crizotinib | High-Quality Pharmaceutical Reference Standard
Crizotinib API is a tyrosine kinase inhibitor used in the treatment of ALK-positive and ROS1-positive non-small cell lung cancer. It blocks oncogenic signaling pathways and is suitable for oral solid dosage forms.
Crizotinib API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.
Total Products : 6
